Statins represent a major class of drugs for treatment of hypercholesterolemia due to their ability to inhibit de novo cholesterol synthesis, namely the rate-limiting step of mevalonate pathway catalyzed by HMG-CoA reductase. Here, HMGCR is linked to Hypercholesterolemia.